FDA Rules: Updating Drug Testing Methods
This bill has moved out of committee and is now waiting for a vote by the full House of Representatives as of June 17, 2026. While reaching this stage is a significant step, the bill is not guaranteed a floor vote because House leaders must decide to schedule it. It remains active but faces a difficult path forward to become law.
This bill has support from both parties and simply helps the FDA follow a law that was already passed. It fixes technical issues and updates rulebooks to match current policy.
This bill’s path across every version that has carried it.
Reintroduced
Reintroduced from H.R. 7248 (118th), which died when its Congress ended.
H.R. 7248 (118th) →Govbase has not yet run an impact analysis on this legislation.
Placed on the Union Calendar, Calendar No. 614.
The bill is now on the schedule for the full chamber to consider. It's in line for debate and a vote.
Reported by the Committee on Energy and Commerce. H. Rept. 119-706.
The committee approved this bill and is sending it to the full chamber for a vote. This is a significant step — most bills never get this far.
Ordered to be Reported by the Yeas and Nays: 44 - 0.
The committee approved this bill and is sending it to the full chamber for a vote. This is a significant step — most bills never get this far.
Committee Consideration and Mark-up Session Held
Forwarded by Subcommittee to Full Committee by Voice Vote.
No votes or news coverage recorded for this bill yet.
Document Type
Congressional Bill
Official Title
FDA Modernization Act 3.0
Analysis generated by AI. Always verify with official sources.